Advertisement

Picture Berlin Partner Top News Captain T Cell Therapies 650x100px
All >

Deals > Austria

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria or involving Austrian organisations.

Total search results: 141 | Ordered by Date (descending)
1 2  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Ygion Biomedical–OTHER: investment, 202405 financing round Series A €15m from Austrian private trust (maybe AVV Investment??) 2024-05-21
Single Use Support–Novo Group: investment, 202405 acquisition of 60% majority share by Novo Holdings 2024-05-15
Zetta Genomics–Apex Ventures: investment, 202402 2nd seed financing round expansion totalling £1.8m incl existing investor Apex Ventures 2024-02-08
ABS Biotechnologies–OBN: investor conference, 202401 supply service ABS Biotechnologies presents at BioSeed 2024 London 2024-01-22
Olgram–OBN: investor conference, 202401 supply service Olgram presents at BioSeed 2024 London 2024-01-22
Evomedis–MC Services: public relations, 202311 service existent by MC Services 2023-11-23
Valanx Biotech–Niederösterreich (govt): investment, 202311 growth financing totalling €2.3m equity + public funding incl existing investor TE 2023-11-07
Valanx Biotech–SEVERAL: investment, 202311 growth financing round €2.3m incl equity + public funding led by SkyGene 2023-11-07
Valanx Biotech–SkyGene: investment, 202311 growth financing round totalling €2.3m in equity + public funding incl new + lead investor SkyGene 2023-11-07
Valanx Biotech–SOSV: investment, 202311 growth financing totalling €2.3m equity + public funding incl existing investor SOSV 2023-11-07
Valanx Biotech–Xista Science Ventures: investment, 202311 growth financing round totalling €2.3m equity + public funding incl existing investor Xista 2023-11-07
HeartBeat.bio–SEVERAL: investment, 202311 financing round pre-Series A €4.5m with i&i Biotech Fund + Invest AG + aws + Tensor Ventures 2023-11-02
CMBlu Energy–STRABAG: investment, 202310 equity investment €100m in connection with preferred partnership agreement 2023-10-23
STRABAG––CMBlu Energy: energy storage solutions, 202310– strategic collab preferred supplier agreement for SolidFlow batteries 2023-10-23
Biotech Austria–MC Services: public relations, 202310 service existent by MC Services 2023-10-17
Kern Tec–EU (govt): investment, 202309 financing round Series A totalling €12m incl co-investor EIC Fund 2023-09-27
Kern Tec–PeakBridge: investment, 202309 financing round Series A totalling €12m incl co-investor PeakBridge Growth 2 fund 2023-09-27
Kern Tec–SEVERAL: investment, 202309 financing round Series A €12m led by Telos Impact (eventually total includes grants?) 2023-09-27
Kern Tec–Telos Impact: investment, 202309 financing round Series A totalling €12m incl lead investor Telos Impact 2023-09-27
Michor Consulting–QbD Group: investment, 202305 acquisition of Michor Consulting by QbD Group 2023-05-25
Zetta Genomics–Apex Ventures: investment, 202304 2nd seed financing round totalling £1.9m incl existing + co-investor Apex Ventures 2023-04-18
Merck (US)–Proxygen: molecular glue degraders, 202304– strategic multi-year collab + license agreem upfront payment + €2.55b milestones plus royalties 2023-04-05
Proxygen–Vida Strategic Partners: public relations, 202304 service existent by Vida Strategic Partners 2023-04-05
Refined Laser Systems–Apex Ventures: investment, 202301 seed financing round totalling €2.7m incl co-lead investor Apex Medical Fund 2023-01-26
Refined Laser Systems–Onsight Ventures: investment, 202301 seed financing round totalling €2.7m incl co-investor Onsight Ventures 2023-01-26
Sarcura–Axilium Holding: investment, 202211 seed plus financing round totalling €7m incl existing + co-investor Axilium Holding 2022-11-17
Sarcura–HCVC: investment, 202211 seed plus financing round totalling €7m incl new + co-investor HCVC 2022-11-17
Sarcura–IST Cube: investment, 202211 seed plus financing round totalling €7m incl existing + co-lead investor IST Cube 2022-11-17
Sarcura–Lansdowne Partners: investment, 202211 seed plus financing round totalling €7m incl existing + co-lead investor Lansdowne Investment Co Cyprus 2022-11-17
Sarcura–Niederösterreich (govt): investment, 202211 seed plus financing round totalling €7m incl new + co-investor Tecnet Equity 2022-11-17
Sarcura–Nina Capital: investment, 202211 seed plus financing round totalling €7m incl existing + co-investor Nina Capital 2022-11-17
Sarcura–Novacapital: investment, 202211 seed plus financing round totalling €7m incl existing + co-investor Novacapital 2022-11-17
Sarcura–OTHER: investment, 202211 seed plus financing round totalling €7m incl European family offices as new investors 2022-11-17
Sarcura–SEVERAL: investment, 202211 seed plus financing round €7m co-led by Lansdowne Investment Co Cyprus + IST Cube 2022-11-17
Celeris Therapeutics–EU (govt): grant, 202210 EIC Accelerator grant €2.5m 2022-10-19
Celeris Therapeutics–EU (govt): investment, 202210 equity investment up to €10m from EIC Accelerator 2022-10-19
Xund Solutions–Lana Ventures: investment, 202209 seed financing round totalling €6m incl co-investor Lana Ventures 2022-09-29
Xund Solutions–MassMutual: investment, 202209 seed financing round totalling €6m incl co-lead investor MassMutual Ventures 2022-09-29
Xund Solutions–MMC Ventures: investment, 202209 seed financing round totalling €6m incl co-lead investor MMC Ventures 2022-09-29
Xund Solutions–Roche: investment, 202209 seed financing round totalling €6m incl co-investor RoX Health 2022-09-29
Xund Solutions–SEVERAL: investment, 202209 seed financing round €6m co-led by MMC Ventures + MassMutual Ventures 2022-09-29
BioDGraft–NLC Ventures: investment, 202209 existent seed investor NLC 2022-09-27
Biosynth Carbosynth–Eucodis Bioscience: industrial enzymes, 202208 collab existent for many years 2022-08-02
Eucodis Bioscience–Biosynth Carbosynth: investment, 202208 acquisition of Eucodis by Biosynth Carbosynth 2022-08-02
Kranus Health–Peak Pride: investment, 202206 financing round Series A totalling >$6.5m incl co-investor Peak Pride 2022-06-20
Merck (DE)–Proxygen: molecular glue degraders, 202206– strategic multi-year collab + license agreem up to €495m plus royalties 2022-06-02
Boehringer–Celeris Therapeutics: targeted protein degraders, 202204– collab AI-based drug discovery for target of Boehringer 2022-04-04
Innovacell–EU (govt): credit, 202203– venture debt loan of up to €15m from EIB to Innovacell AG 2022-03-24
Merck (DE)–Celeris Therapeutics: AI-based drug discovery, 202202– collab research small molecule binders + bifunctional degraders 2022-03-09
Celeris Therapeutics–Apex Ventures: investment, 202202 seed financing round totalling $4.4m incl new + co-lead investor Apex Ventures 2022-02-10
Celeris Therapeutics–i&i Biotech Fund: investment, 202202 seed financing round totalling $4.4m incl new + co-lead investor i&i Biotech Fund 2022-02-10
Celeris Therapeutics–Longevitytech.fund: investment, 202202 seed financing round totalling $4.4m incl existing + co-investor Longevitytech.fund 2022-02-10
Celeris Therapeutics–Pace Ventures Enigma: investment, 202202 seed financing round totalling $4.4m incl new + co-lead investor Pace Ventures Enigma 2022-02-10
Celeris Therapeutics–R42 Group: investment, 202202 seed financing round totalling $4.4m incl existing + co-investor R42 Group 2022-02-10
Celeris Therapeutics–SEVERAL: investment, 202202 seed financing round $4.4m led by Pace Ventures Enigma + i&i Biotech Fund + Apex Ventures 2022-02-10
Zetta Genomics–Apex Ventures: investment, 202202 seed financing round totalling £2.5m incl co-investor Apex Medical 2022-02-01
Zetta Genomics–Univ Cambridge: investment, 202202 seed financing round totalling £2.5m incl co-investor Cambridge Enterprise 2022-02-01
Ribbon Biolabs–SEVERAL: investment, 202201 financing round Series A €18m led by Hadean Ventures 2022-01-31
Ribbon Biolabs–Trophic Communications: public relations, 202201 service existent by Trophic 2022-01-31
Ferring–Cyprumed: drug delivery technology, 202201– collab expansion RnD for oral drug delivery of peptide therapeutics 2022-01-24
Origimm Biotechnology–Sanofi: investment, 202112– acquisition by Sanofi SIGNED 2021-12-01
Innerspace–Austria (govt): investment, 202111 2nd seed financing round totalling 7-digit € incl new investor aws Gründerfonds 2021-11-23
Innerspace–High-Tech Gründerfonds: investment, 202111 2nd seed financing round totalling 7-digit € incl existing investor HTGF 2021-11-23
Innerspace–MAD Ventures: investment, 202111 2nd seed financing round totalling 7-digit € incl existing investor MAD Ventures GmbH 2021-11-23
Innerspace–SEVERAL: investment, 202111 2nd seed financing round 7-digit € with MAD Ventures + HTGF + aws Gründerfonds 2021-11-23
PhagoMed–BioNTech: investment, 202111 acquisition estimated €150m of PhagoMed by BioNTech 2021-11-09
Cutanos–High-Tech Gründerfonds: investment, 202107 1st financing round incl investor HTGF 2021-07-05
Cutanos–IST Cube: investment, 202107 1st financing round incl investor IST Cube 2021-07-05
Cutanos–Khanu Management: investment, 202107 1st financing round incl investor KHAN Technology Transfer Fund I 2021-07-05
Cutanos–OTHER: investment, 202107 1st financing round incl a private investor 2021-07-05
Cutanos–SEVERAL: investment, 202107 1st financing round with KHAN-I + HTGF + IST Cube + another private investor 2021-07-05
Allcyte–Exscientia: investment, 202106– acquisition €50m in cash + ordinary shares ANNOUNCED 2021-06-15
Celeris Therapeutics–Austria (govt): grant, 202105 grant €600k from aws 2021-05-03
Kaia Health–3VC: investment, 202104 financing round Series C totalling $75m incl existing + co-investor 3VC 2021-04-28
PreComb Therapeutics–Kinled: investment, 202104 seed financing round totalling CHF2.2m incl co-lead investor Kinled Austria 2021-04-26
Delta 4–OTHER: investment, 202104 financing round Series A €multi-million closing with addit funding from European Family Office 2021-04-07
Delta 4–SEVERAL: investment, 202104 financing round Series A €multi-million closing with addit funding from European Family Office 2021-04-07
Celeris Therapeutics–Longevitytech.fund: investment, 202103 pre-seed financing round totalling €400k incl investor Longevitytech.fund 2021-03-31
Celeris Therapeutics–R42 Group: investment, 202103 pre-seed financing round totalling €400k incl investor R42 Group 2021-03-31
Celeris Therapeutics–SEVERAL: investment, 202103 pre-seed financing round €400k from R42 Group + Longevitytech.fund 2021-03-31
Allcyte–42cap: investment, 202103 seed financing round totalling $6m incl new investor 42cap 2021-03-25
Allcyte–Air Street Capital: investment, 202103 seed financing round totalling $6m incl new investor Air Street Capital 2021-03-25
Allcyte–Amino Collective: investment, 202103 seed financing round totalling $6m incl new investor Amino Collective 2021-03-25
Allcyte–PUSH Ventures: investment, 202103 seed financing round totalling $6m incl new investor PUSH Ventures 2021-03-25
Allcyte–SEVERAL: investment, 202103 seed financing round $6m incl 42cap + Air Street Capital + PUSH Ventures et al 2021-03-25
Allcyte–VP Venture Partners: investment, 202103 seed financing round totalling $6m incl new investor VP Venture Partners 2021-03-25
Sarcura–Austria (govt): grant, 202103 research grant €1.5m from FFG 2021-03-01
Sarcura–imec: cytometer, 202101– collab developm silicon chip-based prototype of cytometer for automated cell separation 2021-01-31
Cutanos–Max Planck: topical drug delivery technology, 202101– license excl to LC-TDS technology from Max Planck Innovation 2021-01-01
Boehringer–Proxygen: molecular glue degraders, 202012– collab + license agreem developm in combi with PROTACs against oncogenic targets 2020-12-07
Sarcura–Austria (govt): grant, 202011c AWS Seed financing grant 2020-11-19
Sarcura–Axilium Holding: investment, 202011 seed financing round totalling €2.5m incl investor Axilium Capital 2020-11-19
Sarcura–IST Cube: investment, 202011 seed financing round totalling €2.5m incl investor IST cube 2020-11-19
Sarcura–Nina Capital: investment, 202011 seed financing round totalling €2.5m incl investor Nina Capital 2020-11-19
Sarcura–SEVERAL: investment, 202011 seed financing round €2.5m (not specified whether this amount incl AWS Seed grant) 2020-11-19
Apeiron–Domainex: drug discovery services, 202011– collab expansion supply of lead optimisation services for Cbl-b targeting APN431 compound series 2020-11-09
Quantro Therapeutics–Boehringer: investment, 202007 seed financing round from BIVF + Evotec acquiring equal minority stakes 2020-07-21
Quantro Therapeutics–Evotec: drug discovery services, 202007– supply of hit identification services by Evotec 2020-07-21
Quantro Therapeutics–Evotec: investment, 202007 seed financing round from BIVF + Evotec acquiring equal minority stakes 2020-07-21
Quantro Therapeutics–MC Services: public relations, 202007 service existent by MC Services 2020-07-21
1 2  next pagenext page



Advertisement

Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner Top News Captain T Cell Therapies 650x300px

» top